Primary prevention lipid-lowering drug therapy - Response

被引：0
|
作者：
Gotto, AM [1 ]
Kuller, LH
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY 14853 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] AstraZeneca, Wilmington, DE 19850 USA
[4] Bristol Myers Squibb Co, New York, NY 10154 USA
[5] Pfizer, New York, NY 10017 USA
来源：
CIRCULATION | 2002年 / 106卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E35 / E36
页数：2
相关论文
共 50 条
  • [21] Basic mechanisms of stroke prevention with lipid-lowering therapy
    Rosenson R.S.
    Current Atherosclerosis Reports, 2000, 2 (2) : 120 - 125
  • [22] Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease
    Delabays, Benoit
    de La Harpe, Roxane
    Vollenweider, Peter
    Fournier, Stephane
    Muller, Olivier
    Strambo, Davide
    Graham, Ian
    Visseren, Frank L. J.
    Nanchen, David
    Marques-Vidal, Pedro
    Vaucher, Julien
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (17) : 1856 - 1864
  • [23] The use of lipid-lowering drug therapy in children and adolescents
    Avis, Hans J.
    Vissers, Maud N.
    Wijburg, Frits A.
    Kastelein, John J. P.
    Hutten, Barbara A.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (03) : 224 - 231
  • [24] LIFIBROL - A NOVEL LIPID-LOWERING DRUG FOR THE THERAPY OF HYPERCHOLESTEROLEMIA
    LOCKER, PK
    JUNGBLUTH, GL
    FRANCOM, SF
    HUGHES, GS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (01) : 73 - 88
  • [25] Effectiveness of lipid-lowering therapy in primary care in France
    Van Ganse, E
    Moulin, P
    Bertrand, M
    Souchet, T
    Pietri, G
    Yin, DD
    de Pouvourville, G
    VALUE IN HEALTH, 2003, 6 (06) : 643 - 643
  • [26] Effectiveness of lipid-lowering therapy in primary care in France
    Van Ganse, E
    Moulin, P
    Bertrand, M
    Souchet, T
    Pietri, G
    de Pouvourville, G
    VALUE IN HEALTH, 2004, 7 (03) : 319 - 320
  • [27] Effectiveness of lipid-lowering therapy in primary care in France
    van Ganse, E
    Moulin, P
    Bertrand, M
    Souchet, T
    Pietri, G
    Alemao, E
    Yin, D
    de Pouvourville, G
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 155 - 155
  • [28] Landmark Lipid-Lowering Trials in the Primary Prevention of Cardiovascular Disease
    Chrispin, Jonathan
    Martin, Seth S.
    Hasan, Rani K.
    Joshi, Parag H.
    Minder, C. Michael
    McEvoy, John W.
    Kohli, Payal
    Johnson, Amber E.
    Wang, Libin
    Blaha, Michael J.
    Blumenthal, Roger S.
    CLINICAL CARDIOLOGY, 2013, 36 (09) : 516 - 523
  • [29] Primary prevention of cardiovascular disease: Implications of lipid-lowering trials
    Pedersen, TR
    JOURNAL OF HYPERTENSION, 1996, 14 : S195 - S200
  • [30] Prevention of coronary heart diseases and lipid-lowering therapy in Japan
    Saito, Y
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2000, 2 (0D) : D49 - D50
12345